Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Gevo
GEVO
$397M
| $240K | ﹤0.01% |
122,322
-131,767
| -52% | -$215K |
|
3102
Cineverse
CNVS
$55M
| $238K | ﹤0.01% |
70,781
+20,616
| +41% | +$102K |
|
3103
Optex Systems
OPXS
$77.3M
| $237K | ﹤0.01% |
18,394
+2,438
| +15% | +$29.4K |
|
|
AXIA.PR
3104
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $233K | ﹤0.01% |
22,431
| – | – |
|
|
RAPT
3105
DELISTED
RAPT Therapeutics
RAPT
| $231K | ﹤0.01% |
+8,934
| New | +$117K |
|
3106
Pliant Therapeutics
PLRX
$67.5M
| $225K | ﹤0.01% |
151,673
-164,214
| -52% | -$251K |
|
|
FBLA
3107
FB Bancorp
FBLA
$251M
| $224K | ﹤0.01% |
+18,596
| New | +$220K |
|
|
LB
3108
LandBridge Co
LB
$2.12B
| $223K | ﹤0.01% |
+4,182
| New | +$231K |
|
3109
Harvard Bioscience
HBIO
$27.1M
| $218K | ﹤0.01% |
49,614
-63,011
| -56% | -$299K |
|
3110
Rimini Street
RMNI
$408M
| $214K | ﹤0.01% |
45,571
+18,472
| +68% | +$82K |
|
3111
Cosan
CSAN
$2.96B
| $212K | ﹤0.01% |
46,100
+644
| +1% | +$2.97K |
|
3112
The ONE Group
STKS
$57.1M
| $210K | ﹤0.01% |
70,839
+18,435
| +35% | +$57.9K |
|
3113
Protara Therapeutics
TARA
$226M
| $208K | ﹤0.01% |
47,708
-37,595
| -44% | -$122K |
|
3114
Natural Health Trends
NHTC
$15.4M
| $206K | ﹤0.01% |
46,061
+731
| +2% | +$3.33K |
|
3115
PLAYSTUDIOS Inc
MYPS
$79.3M
| $205K | ﹤0.01% |
213,073
-1,895
| -0.9% | -$2.04K |
|
3116
Sonida Senior Living
SNDA
$1.97B
| $204K | ﹤0.01% |
7,368
-11,927
| -62% | -$306K |
|
|
FIRY
3117
Firy Inc
FIRY
$127M
| $203K | ﹤0.01% |
25,369
-3,454
| -12% | -$26.5K |
|
|
PPTA
3118
Perpetua Resources
PPTA
$2.23B
| $202K | ﹤0.01% |
9,986
-15,053
| -60% | -$254K |
|
3119
Greenfire Resources
GFR
$817M
| $200K | ﹤0.01% |
43,163
| – | – |
|
3120
Home Federal Bancorp
HFBL
$67M
| $198K | ﹤0.01% |
14,511
| – | – |
|
|
GAU
3121
Galiano Gold
GAU
$486M
| $197K | ﹤0.01% |
+89,916
| New | +$168K |
|
3122
IZEA Worldwide
IZEA
$59.5M
| $197K | ﹤0.01% |
52,932
-850
| -2% | -$3.12K |
|
3123
Avalon Holdings
AWX
$10.1M
| $195K | ﹤0.01% |
74,597
| – | – |
|
3124
Ginkgo Bioworks
DNA
$481M
| $194K | ﹤0.01% |
13,316
+519
| +4% | +$6.21K |
|
3125
Neumora Therapeutics
NMRA
$276M
| $191K | ﹤0.01% |
104,983
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.